Evaluation of Therapeutic Effects of LED (627 +/- 10nm) The Initial Phase of the Ankle Sprains Treatment

EVALUATION OF THERAPEUTIC EFFECTS OF LED (627 +/- 10nm) THE INITIAL PHASE OF THE ANKLE SPRAINS TREATMENT - A RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02433964

Enrollment

Registered

2015-05-05

Start date

2012-05-31

Completion date

2012-11-30

Last updated

2015-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Sprain

Keywords

laser, LED, PRICE, pain, edema

Brief summary

The purpose of this study is to evaluate the therapeutic effects of the LED (627 +/- 10 nm) with respect to the localized pain and local swelling of ankle sprains in the initial phase.

Detailed description

A variety of therapies for the treatment of sprains has emerged as they occur advances in technological applications. Therapy with coherent and non-coherent light is a treatment modality for a variety of musculoskeletal injuries. The main benefits certificates for phototherapy are the reduction of nociceptive processes, tissue remodeling, among others. The aim of the present paper is to analyze the changes caused by the use of LED (627 +/- 10 nm) with an energy density of 10 J / cm2 in 40 subjects divided into two groups (placebo and LED). All volunteers participating in this study had ankle inversion sprain grade II treated with the price technique. The study was performed in six days. And the results were verified by review of all individuals, through the Visual Analogue Scale (VAS) of pain, McGill Pain Questionnaire and Titrimetry. Measurements were performed at first, third and sixth day's of treatment.

Interventions

OTHERGrupo LED

OTHERPlacebo

ledterapia off + price

Study design

Allocation

RANDOMIZED

Intervention model

FACTORIAL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

18 Years to 22 Years

Healthy volunteers

Inclusion criteria

* Active individuals * With medical referral * With clinical diagnosis of inversion sprain grade II * The day he suffered the injury * Without prescriptions

Exclusion criteria

* Individuals who had previous trauma and orthopedic disorders such as fractures, tendinopathy, previous surgical procedure * Other systemic diseases.

Design outcomes

Primary

Measure	Time frame	Description
edema, measured by volumetry	the development of edema in 6 days	Edema was measured on the first, third and sixth day

Secondary

Measure	Time frame	Description
pain, measured by the Visual Analogue Pain Scale (VAS) and McGill Pain Questionnaire	the evolution of the pain in 6 days	Pain was measured on the first, third and sixth day

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026